glp-1 blood brain barrier uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics Impact of GLP-1 receptor agonists
Description
This could relate to different pharmacokinetic profiles, lower peak drug levels, or differences in how the oral versus injectable forms interact with the nervous system
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Drucker DJ, Brubaker PL
A separate nationwide cohort of older Danish patients found an 11% reduced dementia risk on GLP-1s
Frontiers in Immunology, 6, 120
Their ability to improve metabolic health, reduce systemic inflammation, and lower surgical complication rates makes them valuable in optimizing patient outcomes
A Both/And Conversation I want to be really clear: I am not anti-medication
